FT576

FT576 in Subjects With Multiple Myeloma

More Information

Trial Status
Active, Not Recruiting
Trial Phase
Phase 1
Enrollment
31 patients (estimated)
Sponsors
Fate Therapeutics
Tags
Natural Killer (NK) Cells (Allogeneic)
Trial Type
Treatment
Last Update
2 months ago
SparkCures ID
1226
NCT Identifier
NCT05182073

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.